Cell death in pancreatic cancer: from pathogenesis to therapy
Pancreatic cancer is a devastating gastrointestinal cancer characterized by late diagnosis,
limited treatment success and dismal prognosis. Exocrine tumours account for 95% of …
limited treatment success and dismal prognosis. Exocrine tumours account for 95% of …
Understanding the cell survival mechanism of anoikis-resistant cancer cells during different steps of metastasis
Anchorage-independent survival of cancer cells is associated with metastasis as it enables
cells to travel to secondary target sites. Tissue integrity is generally maintained by …
cells to travel to secondary target sites. Tissue integrity is generally maintained by …
[HTML][HTML] G-quadruplex stabilization via small-molecules as a potential anti-cancer strategy
A Awadasseid, X Ma, Y Wu, W Zhang - Biomedicine & Pharmacotherapy, 2021 - Elsevier
Abstract G-quadruplexes (G4) are secondary four-stranded DNA helical structures
consisting of guanine-rich nucleic acids, which can be formed in the promoter regions of …
consisting of guanine-rich nucleic acids, which can be formed in the promoter regions of …
Pancreatic cancer: basic and clinical aspects
G Schneider, JT Siveke, F Eckel, RM Schmid - Gastroenterology, 2005 - gastrojournal.org
More than 30,000 people develop pancreatic adeno-carcinoma each year in the United
States, and almost all are expected to die from the disease. 1 The 5-year survival rate is 5 …
States, and almost all are expected to die from the disease. 1 The 5-year survival rate is 5 …
Molecular prognostic markers in pancreatic cancer: a systematic review
G Garcea, CP Neal, CJ Pattenden, WP Steward… - European journal of …, 2005 - Elsevier
Pancreatic cancer is one of the most lethal tumours of the gastrointestinal tract. The ability to
predict which patients would benefit most from surgical intervention and/or chemotherapy …
predict which patients would benefit most from surgical intervention and/or chemotherapy …
Combined sonodynamic and antimetabolite therapy for the improved treatment of pancreatic cancer using oxygen loaded microbubbles as a delivery vehicle
C McEwan, S Kamila, J Owen, H Nesbitt, B Callan… - Biomaterials, 2016 - Elsevier
In this manuscript we describe the preparation of an oxygen-loaded microbubble (O 2 MB)
platform for the targeted treatment of pancreatic cancer using both sonodynamic therapy …
platform for the targeted treatment of pancreatic cancer using both sonodynamic therapy …
[HTML][HTML] A G-quadruplex-binding compound showing anti-tumour activity in an in vivo model for pancreatic cancer
SA Ohnmacht, C Marchetti, M Gunaratnam… - Scientific reports, 2015 - nature.com
We report here that a tetra-substituted naphthalene-diimide derivative (MM41) has
significant in vivo anti-tumour activity against the MIA PaCa-2 pancreatic cancer xenograft …
significant in vivo anti-tumour activity against the MIA PaCa-2 pancreatic cancer xenograft …
[HTML][HTML] Apoptosis: targets in pancreatic cancer
S Westphal, H Kalthoff - Molecular cancer, 2003 - Springer
Pancreatic adenocarcinoma is characterized by poor prognosis, because of late diagnosis
and lack of response to chemo-and/or radiation therapies. Resistance to apoptosis mainly …
and lack of response to chemo-and/or radiation therapies. Resistance to apoptosis mainly …
[HTML][HTML] Animal models for bipolar disorder: from bedside to the cage
Bipolar disorder is characterized by recurrent manic and depressive episodes. Patients
suffering from this disorder experience dramatic mood swings with a wide variety of typical …
suffering from this disorder experience dramatic mood swings with a wide variety of typical …
Enhanced antitumour immunity following neoadjuvant chemoradiotherapy mediates a favourable prognosis in women with resected pancreatic cancer
CWF van Eijck, DAM Mustafa, D Vadgama… - Gut, 2024 - gut.bmj.com
Background This study investigates sex disparities in clinical outcomes and tumour immune
profiles in patients with pancreatic ductal adenocarcinoma (PDAC) who underwent upfront …
profiles in patients with pancreatic ductal adenocarcinoma (PDAC) who underwent upfront …